For citations:
Gershtein E.S., Naberezhnov D.S., Alferov A.A., Bezhanova S.D., Frolova N.F., Matveev V.B., Kuslinskii N.E. Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients. Cancer Urology. 2020;16(4):39-47. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-4-39-47